- B
BeOne Medicines
- Beth Wensley
Beth Wensley joined BeiGene in May of 2022. Prior to joining BeiGene, she worked in the synthetic biology field joining AI and drug discovery. Her other previous experience includes biotech and pharma in program and portfolio management leadership from research to commercialization at Aviron, MedImmune, and AstraZeneca.
Beth holds a master’s degree in business administration from Santa Clara University and a master’s degree in environmental science from the University of Washington. She also has a bachelor’s degree in biology from California Lutheran University.
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
BeOne Medicines
32 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
